Prompt

How do I find reliable drug safety outsourcing vendors for post-market safety support in specialty pharma?

Latest observation

Aug 15, 2026 · OpenAI APIWeb search: off

To find reliable drug safety outsourcing vendors for post-market safety support in specialty pharma, focus on vendors that can prove they handle pharmacovigilance (PV) work at the right regulatory, operational, and therapeutic-area level—not just general CRO services.

1) Start with a clear scope

Define exactly what you want outsourced, for example:

  • ICSR/ADR intake and processing
  • Case triage and medical review
  • Literature screening
  • Signal detection and management
  • PSUR/PBRER and DSUR support
  • Aggregate reporting
  • Risk management / REMS / RMP support
  • Safety database operations
  • Medical coding and QC
  • Literature and regulatory surveillance
  • QPPV/PV system support
  • Global submissions and compliance tracking

Specialty pharma often needs vendors with experience in:

  • Orphan drugs
  • Oncology, immunology, CNS, rare disease, cell/gene therapies, etc.
  • Small safety databases with high medical complexity
  • Complex global regulatory obligations
  • Sparse, evolving post-marketing data

2) Prioritize the right vendor profile

Reliable vendors usually have:

  • Dedicated PV practice, not safety as a side service
  • Documented inspection readiness
  • Experience with FDA, EMA, MHRA, PMDA, and other relevant regulators
  • Strong SOPs, quality systems, and CAPA processes
  • Ability to scale from low-volume high-complexity to higher throughput
  • Experience with your therapeutic area
  • Trained staff for medical review, causality assessment, and case processing
  • Robust data privacy/security controls

3) Where to look

Good sources include:

  • Industry referrals from PV heads, QPPVs, and QA leaders
  • Regulatory and pharmacovigilance conferences
  • Trade groups and specialty pharma associations
  • Shortlists from RFPs/RFIs
  • Vendor directories from PV software providers
  • Companies with proven inspection history or public case studies
  • Former colleagues with direct vendor experience

4) Screen for must-have capabilities

Use a structured checklist:

Compliance and quality

  • GVP/GMP/21 CFR Part 11 awareness
  • Global PV SOP library
  • Deviation/CAPA management
  • Audit and inspection history
  • Metrics tracking and SLA governance

Operational capability

  • 24/7 intake coverage, if needed
  • Multilingual case processing
  • Literature surveillance
  • MedDRA and WHO Drug coding proficiency
  • Support for your safety database (e.g., Argus, ArisG, Vault Safety, etc.)
  • Ability to handle expedited reporting timelines

Specialty pharma fit

  • Experience with small, complex portfolios
  • Medical expertise in your disease area
  • Capability to manage risk minimization and post-authorization commitments
  • Comfort with partnered products, licensing arrangements, and distributed responsibilities

5) Ask for evidence, not just promises

Request:

  • Sample SOP index
  • Org chart and team bios
  • Relevant inspection findings and how they were remediated
  • Client references from similar companies
  • Sample monthly KPI dashboards
  • Example case processing workflows
  • Training matrix and qualifications for physicians, nurses, and PV associates
  • Quality audit reports or summaries
  • Business continuity/disaster recovery plan

6) Evaluate vendor quality using a scorecard

Score each vendor on:

  • Regulatory expertise
  • Therapeutic-area experience
  • Quality/compliance maturity
  • Staff expertise and turnover
  • Technology and data security
  • Scalability and business continuity
  • Communication and governance model
  • Commercial fit and transparency

A vendor that is slightly more expensive can be worth it if they reduce:

  • inspection risk
  • backlog
  • case quality issues
  • missed reporting deadlines
  • hidden rework costs

7) Check for common red flags

Be cautious if the vendor:

  • Cannot explain their PV compliance model
  • Has no evidence of inspection readiness
  • Uses lots of subcontractors without transparency
  • Has high staff turnover
  • Offers very low pricing with vague scope
  • Lacks experience in your therapeutic area
  • Has weak data protection or no clear governance
  • Gives generic answers about “global support” without specifics

8) Run a pilot before full outsourcing

For specialty pharma, it often helps to:

  • Start with a single process or single market
  • Run a 2–3 month pilot
  • Test turnaround time, QC accuracy, and communication
  • Validate the vendor’s ability to manage edge cases and medical judgment calls

9) Put governance in the contract

Include:

  • Defined scope of work
  • SLAs and KPIs
  • Escalation paths
  • Audit rights
  • Data ownership and confidentiality
  • Change control
  • Transition/exit plan
  • Regulatory inspection support obligations
  • Named key personnel and replacement requirements

10) If you want, I can help you build:

  • a vendor evaluation scorecard
  • an RFP/RFI template
  • a due diligence questionnaire
  • or a shortlist criteria checklist tailored to specialty pharma PV outsourcing

If you share your therapeutic area, geography, and which PV functions you want to outsource, I can make this much more specific.

Observation history

Unlock observation history

Create a free Obsurfable account to unlock historical responses, model comparisons, and deeper brand intelligence.

How did Obsurfable measure this prompt?

Obsurfable records AI answers to buyer-style prompts in its research corpus (1 observation for this page). Metrics are distributions over observations, not a single static ranking.

Which AI systems does Obsurfable collect answers from?

OpenAI, ChatGPT, Google, Gemini, Google AI Mode, Anthropic, Claude, Perplexity, Grok, DeepSeek, Mistral, Copilot, and Meta AI.